TWD 47.2
(-0.21%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 2.2 Billion TWD | -9.67% |
2022 | 2.43 Billion TWD | 28.46% |
2021 | 1.89 Billion TWD | 92.21% |
2020 | 987.74 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 1.96 Billion TWD | -12.5% |
2024 Q2 | 1.86 Billion TWD | -5.42% |
2023 Q4 | 2.2 Billion TWD | -6.2% |
2023 Q3 | 2.34 Billion TWD | -1.76% |
2023 FY | 2.2 Billion TWD | -9.67% |
2023 Q1 | 2.48 Billion TWD | 24.63% |
2023 Q2 | 2.39 Billion TWD | -3.65% |
2022 FY | 2.43 Billion TWD | 28.46% |
2022 Q4 | 1.99 Billion TWD | 0.0% |
2021 FY | 1.89 Billion TWD | 92.21% |
2020 FY | 987.74 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Allied Biotech Corporation | 72.02 Million TWD | -2958.669% |
GeneFerm Biotechnology Co., Ltd. | 76.14 Million TWD | -2792.981% |
Easywell Biomedicals, Inc. | 330.44 Million TWD | -566.663% |
TTY Biopharm Company Limited | 403.04 Million TWD | -446.58% |
Synmosa Biopharma Corporation | 1.45 Billion TWD | -51.023% |
Center Laboratories, Inc. | 4.42 Billion TWD | 50.261% |
Tien Liang BioTech Co., Ltd. | 377 Thousand TWD | -584243.767% |
Orient Pharma Co., Ltd. | 323.73 Million TWD | -580.49% |
InnoPharmax Inc. | 5.38 Million TWD | -40801.894% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 100.83 Million TWD | -2084.82% |
Excelsior Biopharma Inc. | 300.25 Million TWD | -633.714% |
DV Biomed Co., Ltd. | 315.74 Million TWD | -597.698% |
Foresee Pharmaceuticals Co., Ltd. | 13.11 Million TWD | -16697.377% |
Handa Pharmaceuticals, Inc. | 7.67 Million TWD | -28618.238% |
UniPharma Co., Ltd. | - TWD | -Infinity% |
Anxo Pharmaceutical Co., Ltd. | 499.69 Million TWD | -340.864% |
Alar Pharmaceuticals Inc. | 138 Thousand TWD | -1596259.42% |
Winston Medical Supply Co., Ltd. | 56.05 Million TWD | -3829.886% |
Mercury Biopharmaceutical Corporation | 41.66 Million TWD | -5186.973% |
Bioray Biotech Co., Ltd | 65.65 Million TWD | -3255.382% |
TSH Biopharm Corporation Limited | - TWD | -Infinity% |